4//SEC Filing
Powers Linda F 4
Accession 0001144204-19-003609
CIK 0001072379other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 9:57 PM ET
Size
11.2 KB
Accession
0001144204-19-003609
Insider Transaction Report
Form 4
Powers Linda F
Director10% Owner
Transactions
- Sale
Restricted Common Stock, par value $0.001
2018-12-27$0.17/sh−3,558,639$604,969→ 29,411,760 total - Sale
Restricted Common Stock, par value $0.001
2018-12-28$0.17/sh−804,146$136,705→ 0 total(indirect: Sale by Toucan Capital Fund III, LP.) - Sale
Class D-2 Warrants
2018-12-28−402,073→ 0 total(indirect: Sale by Toucan Capital Fund III, LP.)Exercise: $0.30From: 2018-05-04Exp: 2023-05-04→ Common Stock, par value $0.001 (402,073 underlying) - Sale
Class D-2 Warrants
2018-12-27−1,779,320→ 0 totalExercise: $0.30From: 2018-05-04Exp: 2023-05-04→ Common Stock, par value $0.001 (1,779,320 underlying)
Footnotes (2)
- [F1]Toucan Capital Fund III, LP sold the 804,146 restricted shares of common stock that it owned, in preparation for the required dissolution due to the Toucan Fund reaching the end of its contractual term. The reporting person has management control as well as a partnership interest in the Toucan Fund.
- [F2]The reporting party sold shares of restricted common stock.
Documents
Issuer
NORTHWEST BIOTHERAPEUTICS INC
CIK 0001072379
Entity typeother
Related Parties
1- filerCIK 0001289624
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 9:57 PM ET
- Size
- 11.2 KB